TITLE:
Evaluation of the Effect of Pramlintide on Satiety and Food Intake

CONDITION:
Diabetes Mellitus, Type 1

INTERVENTION:
Pramlintide acetate

SUMMARY:

      This is a single center, randomized, blinded, placebo-controlled, two-period, cross-over
      study to evaluate the effect of pramlintide on satiety and food intake in normal-weight and
      obese non-diabetic subjects and in insulin-treated subjects with type 1 and type 2 diabetes.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: Male
Age: 18 Years to 70 Years
Criteria:

        For Healthy Volunteers:

        BMI >=20 to <=25kg/m2 or >=30 to <=40 kg/m2

        For Subjects with Type 1 or Type 2 Diabetes:

          -  Treated with insulin for at least 6 months prior to screening

          -  HbA1c value between 6.5-10% inclusive

          -  BMI between 20-40kg/m2
      
